Vivo Bio Tech's Q3 Results Show Mixed Growth

Nov 14 2023 12:00 AM IST
share
Share Via
Vivo Bio Tech, a microcap pharmaceutical company, reported a decline in net sales by 20.03% but a significant growth in consolidated net profit by 135.71% for the quarter ended September 2023. Operating profit also saw a positive growth of 8.02%, while interest expenses increased by 7.18%. The company's stock call is currently 'Sell' but its financial performance has shown improvement in the last three months.

Vivo Bio Tech, a microcap pharmaceutical company, recently announced its financial results for the quarter ended September 2023. The company's net sales for the quarter saw a decline of 20.03% compared to the previous quarter, while its consolidated net profit showed a significant growth of 135.71%.

The company's operating profit (PBDIT) also saw a positive growth of 8.02% compared to the previous quarter. However, its interest expenses increased by 7.18% in the same period. Despite this, the company's operating profit margin (excluding other income) has improved from the previous quarter.

According to MarketsMOJO, a leading stock analysis platform, the stock call for Vivo Bio Tech is currently 'Sell'. However, the company's financial performance has shown improvement in the last three months, with its score increasing from 0 to 2.

In terms of positives, Vivo Bio Tech's profit after tax (PAT) for the nine-month period has grown by 1,112.00% year on year, indicating a positive trend. The company's operating profit margin for the quarter was also the highest in the last five quarters, showcasing improved efficiency.

On the other hand, the company's net sales for the quarter have fallen by 29.5% compared to the average of the previous four quarters. This is also the lowest net sales in the last five quarters, indicating a negative trend in the near term.

Despite the mixed financial results, Vivo Bio Tech has shown promising growth in its PAT and operating profit margin. Investors should keep an eye on the company's future performance to make informed decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News